Evidence map›Paper›PMID 17042959›Full record

ArticleBMC infectious diseases2006

Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides.

A Robert Neurath, Nathan Strick, Yun-Yao Li

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 73 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Semen: A modulator of female genital tract inflammation and a vector for HIV-1 transmission.American journal of reproductive immunology (New York, N.Y. : 1989) · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Epigallocatechin Gallate Inhibits Macaque SEVI-Mediated Enhancement of SIV or SHIV Infection.Journal of acquired immune deficiency syndromes (1999) · 2017
    Article
  15. Article
  16. Impact of Sex on the Pharmacokinetics and Pharmacodynamics of 1% Tenofovir Gel.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

A Robert NeurathBiochemical Virology Laboratory, The Lindsley F, Kimball Research Institute of the New York Blood Center, New York, NY 10021, USA. arneurath@att.net
Nathan Strick
Yun-Yao Li
New York Blood Center · US

Funding

SAFETY AND EFFICACY OF CAP IN VIVOP01HD041761 · NICHD · NEW YORK BLOOD CENTER · PI NEURATH, A ROBERT ROBERT · 2001 to 2004
$4.2M
In vivo Safety and Efficacy of CAP and Combination FilmsU19HD048957 · NICHD · NEW YORK BLOOD CENTER · PI NEURATH, A ROBERT ROBERT · 2004 to 2006
$3.9M
NICHD NIH HHS P01 HD041761NICHD NIH HHS P01 HD41761NICHD NIH HHS U19 HD048957
6 · The paper itself

Abstract

backgroundEvaluation of microbicides for prevention of HIV-1 infection in macaque models for vaginal infection has indicated that the concentrations of active compounds needed for protection by far exceed levels sufficient for complete inhibition of infection in vitro. These experiments were done in the absence of seminal plasma (SP), a vehicle for sexual transmission of the virus. To gain insight into the possible effect of SP on the performance of selected microbicides, their anti-HIV-1 activity in the presence, and absence of SP, was determined.

methodsThe inhibitory activity of compounds against the X4 virus, HIV-1 IIIB, and the R5 virus, HIV-1 BaL was determined using TZM-bl indicator cells and quantitated by measuring beta-galactosidase induced by infection. The virucidal properties of cellulose acetate 1,2-benzene-dicarboxylate (CAP), the only microbicide provided in water insoluble, micronized form, in the presence of SP was measured.

resultsThe HIV-1 inhibitory activity of the polymeric microbicides, poly(naphthalene sulfonate), cellulose sulfate, carrageenan, CAP (in soluble form) and polystyrene sulfonate, respectively, was considerably (range approximately 4 to approximately 73-fold) diminished in the presence of SP (33.3%). Formulations of micronized CAP, providing an acidic buffering system even in the presence of an SP volume excess, effectively inactivated HIV-1 infectivity.

conclusionThe data presented here suggest that the in vivo efficacy of polymeric microbicides, acting as HIV-1 entry inhibitors, might become at least partly compromised by the inevitable presence of SP. These possible disadvantages could be overcome by combining the respective polymers with acidic pH buffering systems (built-in for formulations of micronized CAP) or with other anti-HIV-1 compounds, the activity of which is not affected by SP, e.g. reverse transcriptase and zinc finger inhibitors.

Indexed as

SemenAdministration, IntravaginalAnilidesAnti-HIV AgentsCarrageenanCell LineCelluloseDose-Response Relationship, DrugFuransHIV-1HumansNaphthalenesulfonatesPolystyrenesThioamidesAnilidesAnti-HIV AgentsCarrageenanCellulosecellulose acetate 1,2-benzenedicarboxylatecellulose sulfateFuransNaphthalenesulfonatespoly(naphthalenesulfonic acid)Polystyrenespolystyrene sulfonic acidThioamidesUC-781

Identifiers

PMID17042959
PMCPMC1618840
OpenAlexW2168372190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.